Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Danger elements for intrahepatic and extrahepatic cholangiocarcinoma: a scientific evaluate and meta-analysis. J...